share_log

NeueHealth Entered Into A Definitive Merger Agreement To Be Acquired By An Affiliate Of New Enterprise Associates At An Enterprise Value Of ~$1.3B, Or $7.33/Share In Cash

NeueHealth Entered Into A Definitive Merger Agreement To Be Acquired By An Affiliate Of New Enterprise Associates At An Enterprise Value Of ~$1.3B, Or $7.33/Share In Cash

NeueHealth與新企業協會的一個附屬公司達成了正式的合併協議,以大約13億美元的企業價值被收購,現金每股7.33美元。
Benzinga ·  2024/12/23 22:54

NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model.

NeueHealth,Inc.("NeueHealth"或"公司")(紐交所:NEUE),這家以價值爲導向的醫療公司,今天宣佈已達成最終的合併協議,根據該協議,公司將被新企業協會("NEA")的一個關聯公司收購,交易的企業價值約爲13億美元。交易完成後,NeueHealth將成爲一傢俬人持有的公司,擁有繼續推進以價值爲導向的、以消費者爲中心的護理模式的靈活性和資源。

Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash, which represents a premium of approximately 70% over the closing price of NeueHealth common stock on December 23, 2024. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered into rollover agreements pursuant to which such stockholders will continue their investments by exchanging their shares of NeueHealth common stock and/or preferred stock for newly issued equity interests in the privately held company, and the Company's existing secured loan facility with Hercules Capital, Inc. will remain in place.

根據合併協議的條款,NeueHealth普通股的持有者(除將被置換的股份和某些排除的股份外)將每股收到7.33美元的現金,這相當於比2024年12月23日NeueHealth普通股的收盤價溢價約70%。包括NEA及12位現有的NeueHealth投資者(他們共同持有所有未償還的NeueHealth優先股)的某些股東已達成置換協議,根據該協議,這些股東將通過將他們的NeueHealth普通股和/或優先股交換爲新發行的私人持有公司的股權繼續投資,而公司現有的與海格投資的擔保貸款設施將保持不變。

NeueHealth's executive leadership team will continue in their roles upon completion of the transaction and intends to roll over 100% of their equity interests for newly issued equity interests in the privately held company.

交易完成後,NeueHealth的高管團隊將繼續擔任其職務,並計劃將其100%的股權置換爲新發行的私人持有公司的股權。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論